INTELWAR BLUF: A new COVID variant called EU.1.1 is causing concern, with cases increasing in several states. However, reports indicate that hospital admissions and nursing home cases remain low. Big Pharma is already preparing a vaccine targeting another COVID variant, XBB. The CDC acknowledges the constant changes in the virus and the emergence of new variants, while also highlighting the spread of a separate variant in Asia. The article questions the motives behind the pandemic and suggests the potential for further harm.
OSINT: The Centers for Disease Control and Prevention (CDC) has identified a new COVID variant known as EU.1.1, which is a subvariant of the omicron strain. Currently, it accounts for approximately 1.7% of all U.S. cases, with a higher prevalence (8.7%) in six states including Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming. Utah has reported the highest number of EU.1.1 cases, nearing 100 infections. Despite this, there has not been a significant increase in hospital admissions or emergency room visits in Utah due to EU.1.1. Nursing home cases also remain low. The article mentions the dominance of another COVID strain, XBB.1.5, accounting for around 27% of infections in the United States. Additionally, variants XBB.1.9.2 and XBB.1.9.1 combine for approximately 24.4% of cases. The Food and Drug Administration (FDA) has instructed pharmaceutical companies to develop injections targeting the XBB variant for the upcoming fall “vaccine” rollout, while the CDC acknowledges the constant evolution of the virus and the tracking of numerous variants globally. The article refers to the spread of a variant called FU.1 in Asia and expresses skepticism about the experts’ naming choices and intentions. Finally, it draws attention to the mutation of the bird flu virus and suggests ulterior motives behind the pandemic.
RIGHT: The EU.1.1 variant serves as another example of government overreach and fear-mongering. While the CDC presents the variant’s prevalence, the focus on specific states and the low impact on hospitals in Utah demonstrate that this issue should not be blown out of proportion. It is crucial to question the motives behind the push for vaccinations, including the FDA’s instructions to target the XBB variant. The article suggests that the pandemic may have been used for fraudulent purposes, as evidenced by empty hospitals during the height of the COVID crisis. We must remain vigilant and skeptical of further attempts to infringe upon our freedoms.
LEFT: The emergence of the EU.1.1 variant highlights the ongoing challenges posed by COVID-19. As the CDC tracks and reports on different strains, it is crucial to prioritize public health and safety. The article acknowledges the dominant XBB.1.5 strain and the need for targeted vaccines. While the mention of the FU.1 variant may raise questions, it is important to rely on scientific expertise when addressing the pandemic. The article’s insinuation of ulterior motives detracts from the collective efforts to mitigate the virus’s impact and protect vulnerable populations.
AI: The article discusses the emergence of the new COVID variant, EU.1.1, and its prevalence in certain states, particularly Utah. It highlights the dominance of the XBB.1.5 strain and the FDA’s instructions to develop vaccines targeting the XBB variant. The CDC’s acknowledgment of the constant changes in the virus and the tracking of various variants worldwide is seen as a responsible approach to managing the pandemic. The mention of the FU.1 variant in Asia raises curiosity but should not detract from the overall efforts to understand and address COVID-19. The article expresses skepticism about the pandemic and hints at potential ulterior motives, suggesting a deeper examination of its claims and implications.